AzTrials
AzTrials

Cystic FibrosisNCT00688051

Changes in Adherence After Playing "My Life With CF" Game

A study testing My Life with CF game in people with Cystic Fibrosis, run by Children's Mercy Hospital Kansas City at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Nonadherence to treatment regimes among patients with cystic fibrosis (CF) is well documented in the literature. Unfortunately, few interventions have been successful at improving adherence rates in this patient population. Read more about this study

Who is it for?
Ages 12 to 21 yearsHealthy volunteers can take part
Conditions the study is for
Cystic Fibrosis
What is being tested?
My Life with CF game
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
May 2008to May 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • patients with a diagnosis of CF
  • age 12 - 20 years
  • capable of reading and conversing in English
  • capable and willing to provide assent for study participation
  • presence of a parent/guardian capable of providing informed consent

Who cannot join

  • absence of a parent/guardian or unwillingness to provide permission
  • potential participant declines to provide assent
  • the presence of a healthcare condition that does not meet infection control standards (i.e. patients with burkodalia cepacia) for participation in the small group setting necessary to play the game.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Mercy Hospital

    Kansas City, Missouri, 64108

Other trials in United States

About this study

Official title: Changes in Adherence to Diet, Treatment and Medication in the Cystic Fibrosis Patient as a Result of Participation in a Simulation Game.

Nonadherence to treatment regimes among patients with cystic fibrosis (CF) is well documented in the literature. Unfortunately, few interventions have been successful at improving adherence rates in this patient population. Within the pediatric population, specifically adolescents, attitude toward treatment directly effects adherence to treatment. Changing attitude includes making conscious decisions regarding adherence or non-adherence and should include an understanding of what outcomes will likely result from nonadherence.

This study will determine if attitudes can be enhanced and adherence to treatment regimen improved in Cystic Fibrosis (CF) adolescent patients by using a simulation game "My Life with CF" . The target population is CF patients ages 12-21 years. Attitudes will be assessed utilizing four attitude scales in CF adolescents pre and post experiencing the simulation game. In the simulation game, patients make life decisions, including CF therapy decisions, using a fictional character diagnosed with CF. The game has been designed to help players understand the long-term effects of health care choices. Data from this pilot study will assess changes in attitudes and reported changes in adherence.

Read the detailed description

Thirty patients will be enrolled in the study. These volunteer individuals will complete the Attitude Assessment Scale and Diet and Treatment form, play the game and provide demographic data. They will complete the Attitude Assessment Scales again following the game and debriefing. These individuals will complete the Attitude Assessment Scale and Diet and Treatment form a third time, one month after playing the game. Historical review indicates that enrollment for the study can be completed within 10 months after IRB approval is secured. This allows all aspects of the study to be complete within the one year time frame established by the funding agency.

Participants for this study will be identified using study inclusion / exclusion criteria Inclusion criteria are: 1) patients with a diagnosis of CF, 2) age 12 - 20 years, 3) capable of reading and conversing in English, 4) capable and willing to provide assent for study participation, and 5) presence of a parent/guardian capable of providing informed consent. Exclusion criteria are: 1) absence of a parent/guardian or unwillingness to provide permission, 2) potential participant declines to provide assent 3) the presence of a healthcare condition that does not meet infection control standards (i.e. patients with burkodalia cepacia) for participation in the small group setting necessary to play the game. Patients with MRSA will not be excluded from the study. Patients with MRSA can play the game alone, with a CMH staff member, study personnel, or sibling. All infection control measures will be followed according to hospital policy. Members of the study team have identified patients, based on inclusion criteria, who will qualify for the study. A letter will be mailed to these patients with a description of the game, study purpose, and time requirement. A follow-up phone call will be made by a member of the study team to arrange a time when the patient can play the game. Any questions related to study participation will be answered. Consent/assent will be obtained prior to filling out the paper work at the start of the game session.

When a patient is identified for study inclusion, a study investigator will explain the study to the parent/legal guardian and the child. If both these individuals express a willingness to participate, a copy of the informed consent/assent form will be given to them. After both the parent/guardian and child have read and signed the consent/assent form, a copy will be given to each of them and placed in the medical record. The original informed consent/assent form will be kept by the PI with all study materials. The study uses a convenience sampling methodology so no unique study number will be used.

  1. Treatment Groups

There are no treatment groups for this study. Participants will complete an Attitude Assessment Scale and Diet and Treatment form prior to playing the game and complete the Attitude Assessment Scales immediately after the game and debriefing. The Attitude Assessment Scales and Diet and Treatment form will also be filled out again one month after playing the game. In addition, these individuals will provide self-disclosed demographic data, which will be used only to describe the study population.

  1. Drugs/Devices/Experimental Intervention:

The experimental intervention includes playing the game "My Life with CF."

Each participant will complete an assessment regarding diet and treatment adherence, and attitudes toward behaviors associated with 1) belief that luck rather than effort determines what happens to a person in life, 2) belief in personal invulnerability, and 3) making life decisions without including long-term consequences. After the baseline measure has been obtained, participants will play the "My Life with CF" game. The attitude assessment scales will be repeated after the game and debriefing. The attitude assessment scales and Diet and Treatment form will be repeated one month following the game.

  1. Observations and Measurements

Participants will be asked to complete the "Attitude Assessment Scales provided in Appendix B. Attitude Scales 1,2 and 3 are the attitude scales validated for the "My Life" game. Attitude scale 4 was created specifically for the "My Life with CF" game and has not been validated. Each attitude scale has 20 questions and is based on a likert-type scale with 1 strongly disagree to 5 strongly agree. The first three attitude scales focus on the three attitudes which have been shown to influence decision making during adolescence. Attitude scale number one assesses personal invulnerability, attitude scale number two assesses present versus future considerations, and attitude scale number three measures luck versus effort. Attitude scale number 4 has an equal number of questions from the above three categories which are specific to CF.

Data collection will occur through the utilization of a "My Life with CF" Case Report Form provided in Appendix C. All study participants' personal health information will be kept confidential in compliance with Federal Law and institutional guidelines. All research case report forms will be kept in Kathy Christenson's office within a secured cabinet and destroyed in accordance with policy and procedures in place regarding research data.

Conditions
Cystic Fibrosis
Being tested
My Life with CF game
Keywords
Cystic Fibrosis, Adherence to treatment
Medical subject headings
Cystic Fibrosis, Treatment Adherence and Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • My Life with CF gameOther

    Also called My Life with CF

    Play the game My Life with CF

Study groups in NCT00688051
Study groupRoleWhat they receive
1ExperimentalNot described
Receives: Other: My Life with CF game

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine changes in attitude associated with playing the game "My Life with CF".

    Measured: One month follow up

Secondary outcomes (1)
  1. To determine changes in frequency to adherence of treatment plan, specifically related to respiratory treatments and medications, one month after playing the game "My Life with CF".

    Measured: One month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2008 (estimated)
  2. Study startMay 2008
  3. Primary completionMay 2009
  4. Study completionMay 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00688051
Sponsor's protocol ID
07 06-091E
Status last verified
Sep 2014
First submitted
28 May 2008
Last updated
5 Sep 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing My Life with CF game in people with Cystic Fibrosis, run by Children's Mercy Hospital Kansas City at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine changes in attitude associated with playing the game "My Life with CF". (time frame: One month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in